FeesSafety
Pluang+

ADC Therapeutics beats Q3 2026 earnings estimates with rising ZYNLONTA sales and strong cash position.

Company Fundamentals
09 Nov 2026, 23:03 WIB
Stuart Mooney
View Source
Bullish
ADC Therapeutics beats Q3 2026 earnings estimates with rising ZYNLONTA sales and strong cash position.

ADC Therapeutics reported a smaller adjusted loss per share of $0.16 in Q3 2026, beating the expected $0.21 loss, and revenue of $21.72 million, surpassing estimates of $18.7 million. The company’s main product, ZYNLONTA, continues to drive growth, with net product revenue reaching $21 million. ADC holds $189.2 million in cash, securing funding through 2029, and is advancing research on ZYNLONTA for other B-cell cancers, with upcoming presentations and potential regulatory milestones in Japan.

ADC Therapeutics reported a smaller adjusted loss per share of $0.16 in Q3 2026, beating estimates and showing revenue growth to $21.72 million. For readers following the health sector, here is Pluang's market snapshot as of Nov 09, 2026 23:12 WIB: out of 150 priced US health stocks, 118 rose and 32 fell. Notable gainers include IMVT at USD 34.75 (+13.82%), TWST at USD 134.47 (+11.33%), and IOVA at USD 8.87 (+10.26%).

More News

Quadient reports 34.47M shares and 34.09M net voting rights as of October 30, 2026

Quadient reports 34.47M shares and 34.09M net voting rights as of October 30, 2026

Quadient S.A. disclosed its monthly update on shares and voting rights as of October 30, 2026. The company has a total of 34,468,912 ordinary shares and a net total of 34,091,172 voting rights. This information is relevant for shareholders and invest...

Company Fundamentals
Neutral
35 minutes ago
Quadient reports total shares and voting rights as of October 30, 2026.

Quadient reports total shares and voting rights as of October 30, 2026.

Quadient S.A. has disclosed its monthly update on the total number of ordinary shares and voting rights as of October 30, 2026. The company reports 34,468,912 total shares and theoretical voting rights, with 34,091,172 net voting rights. This disclos...

Company Fundamentals
Neutral
35 minutes ago
Nokia transfers 847,057 treasury shares to employees under incentive programs.

Nokia transfers 847,057 treasury shares to employees under incentive programs.

Nokia has transferred 847,057 of its treasury shares to employees participating in its stock-based incentive programs, as per a board decision announced in October 2025. This transfer was done without compensation, fulfilling commitments under the in...

Company Fundamentals
Neutral
1 hour ago
Nokia transfers 847,057 shares to incentive plan participants, reducing its own holdings.

Nokia transfers 847,057 shares to incentive plan participants, reducing its own holdings.

Nokia Corporation transferred 847,057 of its own shares to participants of its equity-based incentive plans without any payment, following a board resolution. This transfer fulfills Nokia's commitments under these plans and reduces the company's own ...

Company Fundamentals
Neutral
1 hour ago
Silvercrest ranks #8 in Nasdaq eVestment Q3 2026 Brand Awareness among mid-sized asset managers

Silvercrest ranks #8 in Nasdaq eVestment Q3 2026 Brand Awareness among mid-sized asset managers

Silvercrest Asset Management Group Inc. was ranked #8 in Nasdaq eVestment’s Q3 2026 Brand Awareness Rankings among mid-sized firms managing $2.5 billion to $40 billion in assets. This ranking reflects strong engagement from consultants and asset owne...

Market News
Bullish
2 hours ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App